Efsevia (Effie) Albanis

Company: Neurogene

Job title: Chief Medical Officer

Seminars:

Delving into the Strategies to Effectively Measure AAV Safety in the Liver when AAV Gene Therapies are Administered Systemically & Intra CSF 10:00 am

• Assessing the importance of the correct patient population to avoid the risk of decompensation  • Leveraging liver biopsies to understand which cells are infiltrating the liver to gain more mechanistic understanding  • Integrating novel monitoring methods to explore where the liver damage has occurred  • Exploring the analysis of red cell morphology to inform on the overall…Read more

day: Day Two

Examining a Variety of Biomarkers as Reliable Indicators of Liver Toxicity 9:30 am

• Understand the mechanism and relationship between transaminase increases and liver damage more clearly • Explore additional indictors of liver toxicity and evaluating their efficacy to accurate measure liver toxicity due to AAV vectorsRead more

day: Day One